References
1. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle
cell disease: Biology, pathophysiology, genetics, translational
medicine, and new research directions. Am J Hematol.2009;84(9):618-625.
2. Adekile AD. What’s new in the pathophysiology of sickle cell disease?Med Princ Pract. 2013;22(4):311-312.
3. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell
disease: reappraisal of the role of hemolysis in the development of
clinical subphenotypes. Blood Rev. 2007;21(1):37-47.
4. Jain S, Gladwin MT. Arginine Metabolism and Nitric Oxide
Bioavailability in Sickle Cell Disease. J Pediatr Hematol Oncol.2010;32(7):e247-248.
5. Hoppe C, Styles L, Vichinsky E. The natural history of sickle cell
disease. Curr Opin Pediatr. 1998;10(1):49-52.
6. Ohene-Frempong K, Weiner S, Sleeper L, et al. Cerebrovascular
accidents in sickle cell disease: rates and risk factors. Blood.1998;91(1):288-294.
7. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by
transfusions in children with sickle cell anemia and abnormal results on
transcranial Doppler ultrasonography. N Engl J Med.1998;339(1):5-11.
8. Galadanci NA, Abdullahi SU, Tabari MA, et al. Primary stroke
prevention in Nigerian children with sickle cell disease (SPIN):
challenges of conducting a feasibility trial. Pediatr Blood
Cancer. 2015;62(3):395-401.
9. Adekile AD, Gupta R, Al-Khayat A, Mohammed A, Atyani S, Thomas D.
Risk of avascular necrosis of the femoral head in children with sickle
cell disease on hydroxyurea: MRI evaluation. Pediatr Blood
Cancer. 2019;66(2):e27503.
10. Adekile AD, Haider MZ. Morbidity, beta S haplotype and alpha-globin
gene patterns among sickle cell anemia patients in Kuwait. Acta
Haematol. 1996;96(3):150-154.
11. Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia.Ann Saudi Med. 2011;31(3):289-293.
12. Asbeutah A, Gupta R, Al-Saeid O, et al. Transcranial Doppler and
brain MRI in children with sickle cell disease and high hemoglobin F
levels. Pediatr Blood Cancer. 2014;61(1):25-28.
13. Adekile AD, Al-Sherida S, Marouf R, Mustafa N, Thomas D. The
Sub-Phenotypes of Sickle Cell Disease in Kuwait. Hemoglobin.2019;43(2):83-87.
14. Akar NA, Adekile A. Ten-year review of hospital admissions among
children with sickle cell disease in Kuwait. Med Princ Pract.2008;17(5):404-408.
15. Bavarsad Shahripour R, Mortazavi MM, Barlinn K, et al. Can STOP
Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell
Disease? Journal of stroke. 2014;16(2):97-101.
16. Adekile A, Hassan M, Asbeutah A, Al-Hinai M, Trad O, Farhan N.
Transcranial Doppler Ultrasound in Peninsular Arab Patients With Sickle
Cell Disease. Journal of ultrasound in medicine : official journal
of the American Institute of Ultrasound in Medicine.2019;38(1):165-172.
17. Gujjar AR, Zacharia M, Al-Kindi S, et al. Transcranial Doppler
ultrasonography in sickle cell disease: a study in Omani patients.J Pediatr Hematol Oncol. 2013;35(1):18-23.
18. Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and
assessment of risk factors based on transcranial Doppler values in the
Gulf region. Hematology. 2020;25(1):55-62.
19. Schurov VA, Muradisinov SO. [Influence of Functional Muscular Test
on Blood Flow Velocity on Medial Cerebral Artery during Treatment of
Patients by G. A. Ilizarov]. Ross Fiziol Zh Im I M Sechenova.2016;102(9):1127-1134.
20. Galadanci N, Abdullahi SU, Vance LD, et al. Feasibility Trial for
Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria
(SPIN Trial). Am J Hematol. 2017.
21. Hankins JS, McCarville MB, Rankine-Mullings A, et al. Prevention of
conversion to abnormal transcranial Doppler with hydroxyurea in sickle
cell anemia: A Phase III international randomized clinical trial.Am J Hematol. 2015;90(12):1099-1105.
22. Opoka RO, Hume HA, Latham TS, et al. Hydroxyurea to lower
transcranial Doppler velocities and prevent primary stroke: the Uganda
NOHARM sickle cell anemia cohort. Haematologica.2020;105(6):e272-e275.
23. Adekile AD, Yacoub F, Gupta R, et al. Silent brain infarcts are rare
in Kuwaiti children with sickle cell disease and high Hb F. Am J
Hematol. 2002;70(3):228-231.
24. Marouf R, Gupta R, Haider MZ, Adekile AD. Silent brain infarcts in
adult Kuwaiti sickle cell disease patients. Am J Hematol.2003;73(4):240-243.
25. Adekile A, Al-Kandari M, Haider M, Rajaa M, D’Souza M, Sukumaran J.
Hemoglobin F concentration as a function of age in Kuwaiti sickle cell
disease patients. Med Princ Pract. 2007;16(4):286-290.
26. Alsultan A, Alabdulaali MK, Griffin PJ, et al. Sickle cell disease
in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype
is not benign. Br J Haematol. 2014;164(4):597-604.